CN Bio and Altis Biosystems, Inc. (“Altis”), leading developers of in vitro human organ models that optimize the accuracy and efficiency of drug development, today announced a strategic partnership.

Researchers can now order their mutation of choice in bit.bio’s opti-ox TM powered human-iPSC derived cells, receiving consistent, defined, cryopreserved products that can be immediately incorporated ...

For the first time, scientists can now leverage the reproducibility of ioCells to study how the four major CNS cell types interact and contribute to neurological diseases. This enables more precise ...

Greg Bowman, a University of Pennsylvania biophysicist, had the kind of idea biotech venture capitalists salivate over. His lab had been working on how to drug “cryptic sites” on proteins that were ...

The series that once defined A&E Network will be revived starting in the spring as a recurring program tied to current headlines, milestone anniversaries and newly unearthed material about famous ...

Mid-20th-century was one of the most exciting and glamorous times in fashion. A world where photography was just developing as an art form thanks to Helmut Newton, Irving Penn and their peers. A world ...

SOMERVILLE, Mass., December 04, 2024--(BUSINESS WIRE)--bluebird bio, Inc. (NASDAQ: BLUE) ("bluebird bio") today announced it has reached an agreement with the Center for Medicare and Medicaid ...

The Model 422 electro-eluter is an electroelution cell for preparative recovery of biomolecules from agarose and acrylamide gels. The eluter combines with the tank and lid of the Mini Trans-Blot® cell ...